After having surgery for uveitis-associated cataracts, patients who had experienced more uveitis attacks required longer ...
The FDA has cleared PRF Technologies’ Investigational New Drug application for OcuRing-K, enabling a Phase 2 U.S. trial in late 2026 to evaluate sustained-release pain and inflammation control after ...
The Apple Vision Pro continues to prove its potential in the medical field, with the headset now seeing use for cataract ...
Apple's Vision Pro has hit another medical-use milestone, with a New York ophthalmologist becoming the first surgeon to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results